StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 02/22/2013 -- StockRunway.com carries trending hot stocks of the day, which remained in news due to their trading activity – AMARANTUS BIOSCI (OTC:AMBS), Growlife (OTC:PHOT) and JOURNAL RADIOLOGY (OTC:JRRD) are in in focus.
AMARANTUS BIOSCI INC (OTC:AMBS) started its trading session with the price $0.07, and closed at price of $0.0640 by decreasing -12.33%.
AMBS was a loser in the 5 days activity and slipped about -26.44%. The one month performance of stock was negative and it plunged more than -38.46%.
What AMBS’s Charts Are Signaling for Traders? Find Out Here
AMBS’s stocks traded with total volume of 11.97 million shares while the average trading capacity remained 11.52 million shares. The beta of the AMBS stands at -107.89. Day range of the stock was $0.06 -$0.07. Amarantus BioScience, Inc. (AMBS) is a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis centered on its patented therapeutic protein Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF).
Is AMBS a Solid Investment at These Levels? Read This Report For Details
Growlife Inc (OTC:PHOT) stock is at $0.0600, down -18.37 percent from its previous close of $0.07. The stock opened the session at $0.07 and touched its highest price point at $0.07. PHOT stock’s lowest price point for the session stood at $0.06.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive with 44.58% during previous three months trade.
How Should Investors Trade PHOT Now? Don’t Miss out a Special Trend Analysis
Its today’s volume is 10.90 million shares in comparison to its usual trading volume of 12.60 million shares. Its beta value stands at 75.95 points. GrowLife, Inc. (PHOT), a provider of highly effective indoor growing technologies, reported that it has entered into a strategic licensing letter of intent with GrowLife Consulting Colorado, LLC ("GLCC"). Under the agreement, GLCC is authorized to use the name "GrowLife" in Colorado, as well as certain intellectual property and technology rights in exchange for licensing fees. The LOI between GrowLife and GLCC is scheduled to close on March 8, 2013.
JOURNAL RADIOLOGY IN (OTC:JRRD) stock is at $0.0007. Its today’s volume is 8.07 million shares in comparison to its usual trading volume of 6.42 million shares. The stock opened the session at $0.0008.
Can Investors Bet on JRRD after this News update? Find out in this Research Report
JRRD lowest price point for the session stood at $0.0007, and its 52 week price range stood at $0.0007 - $0.20. The company total market capitalization is $1.25 million.
Previous 5 days graph demonstrated a negative move of -65%. JRRD’s quarterly performance remained red with the percentage of -99.18, while its year to date performance showed that the stock plunged overall -96.5%. Journal of Radiology Inc. (JRRD) completed its latest international trip with more success in Europe. The 10 day trip through Germany, Austria, Belgium and Netherlands completed many meetings with both immediate sales and long term potential.
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
For more information on this press release visit: http://www.sbwire.com/press-releases/trending-penny-stocks-amarantus-biosci-otcambs-growlife-otcphot-journal-radiology-otcjrrd-211428.htm